Please assess the completion status of the following clinical trial:

Trial Title: Statins for Oxidative Stress and Mitochondrial Function in Diabetic Polyneuropathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years old and older~* Type 2 Diabetes Mellitus according to American Diabetes Association~* Diabetic Polyneuropathy by Dyck et. al. criteria~* HbA1c \<12%~* Informed consent signed~Exclusion Criteria:~* Renal or hepatic failure~* Pregnant or breastfeeding~* Other neuropathies (alcohol-induced, radiculopathy, autoimmune, cancer-related)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- placebo (Type: PLACEBO_COMPARATOR): calcined magnesia 100 mg tablets once a day for 16 weeks
- ezetimibe/simvastatin (Type: ACTIVE_COMPARATOR): ezetimibe/simvastatin 10/20 mg tablets once a day for 16 weeks
- rosuvastatin (Type: ACTIVE_COMPARATOR): rosuvastatin 20 mg tablets once a day for 16 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).